Anesth Analg 2000;91:220-224
© 2000 International Anesthesia Research Society
GENERAL ARTICLES
Carbon Dioxide Absorbents Containing Potassium Hydroxide Produce Much Larger Concentrations of Compound A from Sevoflurane in Clinical Practice
Michiaki Yamakage, MD, PhD,
Shigeyuki Yamada, MD,
Xiangdong Chen, MD,
Sohshi Iwasaki, MD,
Naoki Tsujiguchi, MD, and
Akiyoshi Namiki, MD, PhD
Department of Anesthesiology, Sapporo Medical University School of Medicine, Sapporo, Japan
Address correspondence and reprint requests to Michiaki Yamakage, MD, PhD, Department of Anesthesiology, Sapporo Medical University School of Medicine, South 1, West 16, Chuo-ku, Sapporo, Hokkaido 060-8543, Japan Address e-mail to yamakage{at}sapmed.ac.jp
We investigated the concentrations of degraded sevoflurane Compound A during low-flow anesthesia with four carbon dioxide (CO2) absorbents. The concentrations of Compound A, obtained from the inspiratory limb of the circle system, were measured by using a gas chromatograph. In the groups administered 2 L/min fresh gas flow with 1% sevoflurane, when the conventional CO2 absorbents, WakolimeTM (Wako, Tokyo, Japan) and DrägersorbTM (Dräger, Lübeck, Germany), were used, the concentrations of Compound A increased steadily from a baseline to 14.3 ppm (mean) and 13.2 ppm, respectively, at 2 h after exposure to sevoflurane. In contrast, when the other novel types of absorbents containing decreased or no potassium hydroxide/sodium hydroxide, MedisorbTM (Datex-Ohmeda, Louisville, CO) and AmsorbTM (Armstrong, Coleraine, Northern Ireland), were used, Compound A remained at baseline (<2 ppm) throughout the study. In the groups administered 1 L/min fresh gas flow with 2% sevoflurane, WakolimeTM and DrägersorbTM produced much larger concentrations of Compound A (35.4 ppm and 34.2 ppm, respectively) at 2 h after exposure to sevoflurane. MedisorbTM showed measurable concentrations of Compound A (8.6 ppm at 2 h), but they were significantly smaller than those produced by the two conventional absorbents. In contrast, when AmsorbTM was used, Compound A concentrations remained at baseline throughout the study period.
Implications: Carbon dioxide absorbents containing potassium hydroxide/sodium hydroxide produce much larger concentrations of Compound A from sevoflurane in clinical practice. An absorbent containing neither potassium hydroxide nor sodium hydroxide produces the smallest concentrations of Compound A.
This article has been cited by other articles:

|
 |

|
 |
 
R. Alleva, M. Tomasetti, M. D. Solenghi, F. Stagni, F. Gamberini, A. Bassi, P. M. Fornasari, G. Fanelli, and B. Borghi
Lymphocyte DNA damage precedes DNA repair or cell death after orthopaedic surgery under general anaesthesia
Mutagenesis,
September 1, 2003;
18(5):
423 - 428.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Higuchi, Y. Adachi, S. Arimura, M. Kanno, and T. Satoh
The Carbon Dioxide Absorption Capacity of Amsorb(R) is Half That of Soda Lime
Anesth. Analg.,
July 1, 2001;
93(1):
221 - 225.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. I. Mazze and H. Higuchi
Composition of CO2 Absorbents
Anesth. Analg.,
May 1, 2001;
92(5):
1356 - 1357.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Versichelen, M. P. Bouche, M. Struys, J. Van Bocxlaer, E. Mortier, A. P. de Leenheer, and G. Rolly
Compound A production from sevoflurane is not less when KOH-free absorbent is used in a closed-circuit lung model system
Br. J. Anaesth.,
March 1, 2001;
86(3):
345 - 348.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. I. Mazze
Novel CO2 Absorbents and Low-Flow Sevoflurane
Anesth. Analg.,
December 1, 2000;
91(6):
1562 - 1563.
[Full Text]
[PDF]
|
 |
|
|